Our results regarding the CTR expression in MTC and its correlation with patients’ prognosis are more alike the breast cancer model, namely regarding the tendency for CTR to be more expressed in smaller tumors, without invasion and metastases. This evidence concerns the gene CALCR and breast carcinoma.